PMVP SCHEDULE 13G/A: SEC filing
Tang Capital Management LLC and affiliated entities
Filed with the SEC on · accession 0001214659-26-014414
PMVP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Tang Capital Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 7,572,727 shares (9.99%) of PMV Pharmaceuticals common stock, including shares issuable upon exercise of warrants.
Summary of the filing
Tang Capital Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 7,572,727 shares (9.99%) of PMV Pharmaceuticals common stock, including shares issuable upon exercise of warrants. The filing also discloses ownership of 11,000,000 pre-funded warrants and 14,040,000 common stock warrants, subject to a 9.99% ownership blocker.
Key details
✦ Ask GOAX AI about this filing — what it means for PMVP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PMVP?
Click hereFrequently asked questions
What did PMVP file with the SEC on Nov 16, 2026?
PMVP filed a SCHEDULE 13G/A (SEC filing). Tang Capital Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 7,572,727 shares (9.99%) of PMV Pharmaceuticals common stock, including shares issuable upon exercise of warrants. The filing also discloses ownership of 11,000,000 pre-funded warrants and 14,040,000 common stock warrants, subject to a 9.99% ownership blocker.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other PMVP SEC filings
- 10-Q · SEC filingNov 10, 2026
- 8-K · SEC filingNov 10, 2026
- 8-K · Board changeOct 5, 2026
- 424B5 · Secondary offeringSep 2, 2026
- 8-K · Secondary offeringSep 2, 2026
- 424B3 · Secondary offeringAug 31, 2026
- 424B5 · Secondary offeringAug 31, 2026
- 8-K · Fda approvalAug 31, 2026
- 10-Q · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
Get alerts when PMVP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days